Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression
Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants o...
Saved in:
Published in | BMC pharmacology Vol. 3; no. 1; p. 16 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
20.12.2003
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.
Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.
It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression. |
---|---|
AbstractList | Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.
Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.
It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression. BACKGROUND: Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity. RESULTS: Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-α (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-α expression in the myocardium and was associated with reduced myocyte injury. CONCLUSIONS: It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-α expression. Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.BACKGROUNDOxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart vulnerable to oxidative stress-induced damage. Chronic oral administration of garlic has been reported to enhance the endogenous antioxidants of heart. We hypothesized that garlic-induced enhanced cardiac antioxidants may offer protection against acute adriamycin-induced cardiotoxicity.Rats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.RESULTSRats were either administered freshly prepared garlic homogenate (250 and 500 mg/kg daily, orally, for 30 days) or probucol (cumulative dose, 120 mg/kg body weight divided in 12, i.p. over a period of 30 days) or double distilled water (vehicle), followed by a single dose of adriamycin (30 mg/kg i.p.). In the adriamycin group, increased oxidative stress was evidenced by a significant increase in myocardial TBARS (thiobarbituric acid reactive substances) and decrease in myocardial SOD (superoxide dismutase), catalase and GPx (glutathione peroxidase) activity. Histopathological studies showed focal as well as subendocardial myocytolysis with infiltration of macrophages, lymphocytes and edema. Immunocytochemistry showed marked expression of TNF-alpha (tumor necrosis factor-alpha) in the myocardium. Increase in myocardial TBARS and decrease in endogenous antioxidants by adriamycin was prevented significantly in the garlic treated rat hearts, which was comparable to the probucol-treated group. Histopathological evidence of protection was also evident in both garlic-treated and probucol-treated groups. Probucol, 250 mg/kg and 500 mg/kg of garlic reduced adriamycin induced TNF-alpha expression in the myocardium and was associated with reduced myocyte injury.It is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression.CONCLUSIONSIt is concluded that chronic garlic administration prevents acute adriamycin-induced cardiotoxicity and decreases myocardial TNF-alpha expression. |
ArticleNumber | 16 |
Author | Talwar, Kewal K Mukherjee, Sumanta Maulik, Mohua Dinda, Amit Kumar Maulik, Subir Kumar Banerjee, Sanjay Kumar |
AuthorAffiliation | 2 Department of Pathology, All India Institute of Medical sciences, New Delhi – 110029 India 3 Department of Cardiology, All India Institute of Medical sciences, New Delhi – 110029 India 1 Department of Pharmacology, All India Institute of Medical sciences, New Delhi – 110029 India |
AuthorAffiliation_xml | – name: 3 Department of Cardiology, All India Institute of Medical sciences, New Delhi – 110029 India – name: 1 Department of Pharmacology, All India Institute of Medical sciences, New Delhi – 110029 India – name: 2 Department of Pathology, All India Institute of Medical sciences, New Delhi – 110029 India |
Author_xml | – sequence: 1 givenname: Sumanta surname: Mukherjee fullname: Mukherjee, Sumanta – sequence: 2 givenname: Sanjay Kumar surname: Banerjee fullname: Banerjee, Sanjay Kumar – sequence: 3 givenname: Mohua surname: Maulik fullname: Maulik, Mohua – sequence: 4 givenname: Amit Kumar surname: Dinda fullname: Dinda, Amit Kumar – sequence: 5 givenname: Kewal K surname: Talwar fullname: Talwar, Kewal K – sequence: 6 givenname: Subir Kumar surname: Maulik fullname: Maulik, Subir Kumar |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/14687418$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Ustu1DAUtVARfcCWJfKKXYodJ3aCxKKqaEGqAKGytvy4nhol9mAnaOYT-Bx-pN-Ew5TSgrq69r3nceXjQ7QXYgCEnlNyTGnHX9FG0KquKalYRfkjdHDb2Ltz3keHOX8lhIquEU_QPm14JxraHaAfn1KcwEw-BqxWyoc8YWXmCbCyyatxa3yofLCzAYuNStbHKW688dMW6y1eqTR48xp_jgPg6DAEG1cQ4pyxCkV0422py8ViH6689r-dCvLyw1l1_RPDZp0g59J8ih47NWR4dlOP0Jezt5en76qLj-fvT08uKs3ajleCEWcpqNq6vm1b5rhzWhDbcQatEFrURjS6ZT1XNTje986RroHWdc71jGh2hN7sdNezHsEaCFNSg1wnP6q0lVF5eX8S_JVcxe-S1U1DaOGf7Pjaxwf49ycmjnJJQi5JSCYpLxovb3ZI8dsMeZKjzwaGQQUobycFbQWnoi_AF3eXvXX5E2ABHO8AJsWcE7i_ECKXH_K_dfMPoWSpllTKsn54iPYLPyXD6w |
CitedBy_id | crossref_primary_10_1016_j_bcp_2013_07_005 crossref_primary_10_2298_HEMIND0803197I crossref_primary_10_1007_s11033_007_9112_4 crossref_primary_10_1016_j_cbi_2019_03_012 crossref_primary_10_3390_ijms26010387 crossref_primary_10_1016_j_niox_2012_03_004 crossref_primary_10_3136_fstr_25_449 crossref_primary_10_1111_cas_12186 crossref_primary_10_1177_0960327115627685 crossref_primary_10_3389_fphar_2019_01030 crossref_primary_10_3923_ijp_2008_466_471 crossref_primary_10_1093_jn_nxaa144 crossref_primary_10_1080_15376516_2021_1965274 crossref_primary_10_3109_13880209_2010_517758 crossref_primary_10_1002_cbf_2907 crossref_primary_10_1016_j_fct_2010_01_005 crossref_primary_10_2478_sjecr_2018_0019 crossref_primary_10_1097_CRD_0b013e3181b8e4c8 crossref_primary_10_1210_en_2013_1399 crossref_primary_10_1007_s12011_010_8875_y crossref_primary_10_1007_s11010_005_5905_8 crossref_primary_10_1016_j_soncn_2005_04_004 crossref_primary_10_1139_Y09_051 crossref_primary_10_12659_MSM_881711 crossref_primary_10_1007_s00210_020_01991_2 crossref_primary_10_1002_mnfr_200700078 crossref_primary_10_1016_j_etap_2018_01_007 crossref_primary_10_7314_APJCP_2013_14_11_6379 crossref_primary_10_1021_jf0518002 crossref_primary_10_1016_j_nut_2011_08_006 crossref_primary_10_1039_C6FO00423G crossref_primary_10_3390_nu15153402 crossref_primary_10_1007_s10549_011_1693_x crossref_primary_10_3844_ajptsp_2010_103_108 crossref_primary_10_1152_japplphysiol_00776_2009 crossref_primary_10_1080_22297928_2019_1708789 crossref_primary_10_1007_s11010_013_1830_4 crossref_primary_10_1089_ars_2011_3965 crossref_primary_10_1161_CIRCULATIONAHA_121_058411 crossref_primary_10_1007_s10753_017_0680_8 crossref_primary_10_1016_j_jff_2022_105212 crossref_primary_10_3389_fcvm_2022_921609 crossref_primary_10_1111_j_1365_2613_2007_00561_x crossref_primary_10_1002_mnfr_201500656 crossref_primary_10_1016_j_ijcard_2006_01_010 crossref_primary_10_1080_10520295_2019_1647457 crossref_primary_10_1097_00029330_200608010_00009 crossref_primary_10_1177_1753944713516532 crossref_primary_10_1097_ACO_0b013e3281f8d0eb crossref_primary_10_1039_C3FO60292C crossref_primary_10_1007_s10565_007_9016_z crossref_primary_10_3390_plants11151920 crossref_primary_10_1016_j_bbrc_2015_10_126 crossref_primary_10_1155_2016_1320365 crossref_primary_10_1152_ajprenal_00183_2022 crossref_primary_10_2298_AVB0806583C crossref_primary_10_1016_j_fct_2009_02_007 crossref_primary_10_1186_1475_2891_3_10 crossref_primary_10_3390_nu15112510 crossref_primary_10_1097_01_EHX_0000444077_09624_b1 crossref_primary_10_1139_Y10_071 crossref_primary_10_1007_s10068_015_0083_2 crossref_primary_10_1007_s00262_011_1117_0 crossref_primary_10_3390_antiox11010048 crossref_primary_10_3109_01480545_2011_598531 crossref_primary_10_1089_ars_2009_2947 crossref_primary_10_1177_153303460800700102 crossref_primary_10_1684_bdc_2013_1741 crossref_primary_10_1517_14740338_5_6_791 crossref_primary_10_1016_j_fshw_2013_01_002 crossref_primary_10_18081_ajbm_2333_5106_013_12_23_27 crossref_primary_10_3390_antiox10030338 crossref_primary_10_1016_j_fct_2010_04_007 crossref_primary_10_29333_ejgm_82791 crossref_primary_10_1007_s11130_005_5103_x crossref_primary_10_3109_0886022X_2011_589952 crossref_primary_10_1177_0960327113493304 crossref_primary_10_3892_mmr_2013_1554 crossref_primary_10_1016_j_biopha_2017_04_033 crossref_primary_10_1152_ajplung_00264_2010 crossref_primary_10_1139_cjpp_2012_0315 crossref_primary_10_1016_j_coph_2022_102187 crossref_primary_10_1016_j_fct_2010_02_008 crossref_primary_10_1016_j_jff_2017_12_008 crossref_primary_10_3109_13880209_2015_1070879 crossref_primary_10_1016_j_jsps_2021_06_004 crossref_primary_10_1155_2013_934239 crossref_primary_10_1007_s10616_014_9695_2 crossref_primary_10_1080_15569543_2021_1912099 crossref_primary_10_1016_j_ijcard_2010_04_008 crossref_primary_10_1007_s10238_011_0165_2 crossref_primary_10_1007_s00394_021_02482_7 crossref_primary_10_1179_1351000214Y_0000000088 crossref_primary_10_1139_y11_020 crossref_primary_10_1017_S0007114507793911 crossref_primary_10_1007_s10735_024_10235_z crossref_primary_10_1016_j_jpurol_2013_03_010 |
Cites_doi | 10.1016/B978-0-12-091302-2.50032-3 10.1016/S0024-3205(98)00302-6 10.1006/phrs.2000.0769 10.1016/0003-2697(79)90738-3 10.1161/01.CIR.97.14.1382 10.1177/40.8.1377736 10.1016/S0076-6879(81)77046-0 10.1016/0005-2760(82)90251-X 10.1016/0003-9861(59)90090-6 10.1080/01635589409514341 10.1016/S0003-4975(97)01297-6 10.1042/bj1280147 10.1016/S0021-9258(17)35746-0 10.1161/01.RES.84.4.392 10.7326/0003-4819-80-2-249 10.1177/106002809402800912 10.1073/pnas.88.12.5360 10.1161/01.RES.81.4.627 10.1016/S0022-2828(08)80008-9 10.1161/01.CIR.91.1.10 10.1016/S0024-3205(01)01514-4 10.1139/y87-305 10.1186/1471-2210-2-16 10.1056/NEJM199704103361506 10.1161/01.RES.79.2.162 10.1248/bpb.22.698 |
ContentType | Journal Article |
Copyright | Copyright © 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
Copyright_xml | – notice: Copyright © 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. 2003 Mukherjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1186/1471-2210-3-16 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1471-2210 |
EndPage | 16 |
ExternalDocumentID | PMC324401 oai_biomedcentral_com_1471_2210_3_16 14687418 10_1186_1471_2210_3_16 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 23N 2VQ 2WC 4.4 53G 6J9 AAFWJ AAYXX ACGFO ACGFS ADBBV ADRAZ ADUKV AHBYD AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BFQNJ BMC C1A C6C CITATION CS3 DIK DU5 E3Z EBS EJD EMB EMOBN F5P HH5 HYE IAO IHR INH INR KQ8 M48 MK0 ML~ O5R O5S OK1 OVT P2P PGMZT RNS ROL RPM RSV SBL SOJ SV3 TR2 W2D WOQ WOW XSB ACRMQ ADINQ C24 CGR CUY CVF ECM EIF M~E NPM 7X8 ABVAZ AFGXO AFNRJ 5PM |
ID | FETCH-LOGICAL-b3586-730fd1ea2df95553f6ffb70d863e577b72c74b5396a2ef699ff084e5f8ff930b3 |
IEDL.DBID | M48 |
ISSN | 1471-2210 |
IngestDate | Thu Aug 21 18:20:31 EDT 2025 Wed May 22 07:12:33 EDT 2024 Fri Jul 11 05:23:47 EDT 2025 Sat Sep 28 07:43:53 EDT 2024 Tue Jul 01 02:10:14 EDT 2025 Thu Apr 24 23:02:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b3586-730fd1ea2df95553f6ffb70d863e577b72c74b5396a2ef699ff084e5f8ff930b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1471-2210-3-16 |
PMID | 14687418 |
PQID | 71576179 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_324401 biomedcentral_primary_oai_biomedcentral_com_1471_2210_3_16 proquest_miscellaneous_71576179 pubmed_primary_14687418 crossref_primary_10_1186_1471_2210_3_16 crossref_citationtrail_10_1186_1471_2210_3_16 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-12-20 2003-Dec-20 20031220 |
PublicationDateYYYYMMDD | 2003-12-20 |
PublicationDate_xml | – month: 12 year: 2003 text: 2003-12-20 day: 20 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC pharmacology |
PublicationTitleAlternate | BMC Pharmacol |
PublicationYear | 2003 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | LA Krishenbaum (50_CR8) 1993; 265 SE Steare (50_CR9) 1995; 276 H Okhawa (50_CR17) 1979; 95 D Harman (50_CR32) 1991; 88 DR Meldrum (50_CR14) 1998; 65 RH Blum (50_CR1) 1974; 80 C Kupatt (50_CR15) 1999; 84 B Halliwell (50_CR31) 1989 JR Neely (50_CR16) 1972; 1 SY Saad (50_CR27) 2001; 43 KJ Davies (50_CR24) 1986; 261 CF Seifert (50_CR7) 1994; 28 SK Banerjee (50_CR12) 2002; 70 N Siveski-Iliskovic (50_CR10) 1995; 91 A Wendel (50_CR21) 1981; 77 M Itosuro (50_CR22) 1998; 63 MA Bogoyevitch (50_CR35) 1996; 79 LK Annikki (50_CR23) 1992; 40 B Rietz (50_CR11) 1995; 134 K Sugioka (50_CR25) 1982; 713 S Koima (50_CR2) 1993; 266 B Bozkunt (50_CR34) 1998; 97 H Aebi (50_CR4) 1974 P Kakkar (50_CR20) 1984; 21 PJ Barnes (50_CR36) 1997; 336 GL Ellman (50_CR18) 1959; 82 H Aebi (50_CR19) 1974 ME Billingham (50_CR3) 1978; 62 T Hemnani (50_CR30) 1998; 42 C Mayer (50_CR5) 1983; 10 R Kojima (50_CR29) 1994; 22 SK Banerjee (50_CR13) 2002; 2 LE Weinberg (50_CR26) 1987; 65 T Kubota (50_CR33) 1997; 81 I Morishima (50_CR28) 1998; 63 Y Nagata (50_CR6) 1999; 22 12182765 - BMC Pharmacol. 2002 Aug 16;2:16 7329310 - Methods Enzymol. 1981;77:325-33 9314845 - Circ Res. 1997 Oct;81(4):627-35 2052612 - Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3 8371168 - J Pharmacol Exp Ther. 1993 Sep;266(3):1699-704 9485242 - Ann Thorac Surg. 1998 Feb;65(2):439-43 36810 - Anal Biochem. 1979 Jun;95(2):351-8 6340204 - Semin Oncol. 1983 Mar;10(1 Suppl 1):53-5 7803884 - Ann Pharmacother. 1994 Sep;28(9):1063-72 10874342 - Indian J Physiol Pharmacol. 1998 Oct;42(4):440-52 667860 - Cancer Treat Rep. 1978 Jun;62(6):865-72 10443465 - Biol Pharm Bull. 1999 Jul;22(7):698-702 9091804 - N Engl J Med. 1997 Apr 10;336(15):1066-71 11401411 - Pharmacol Res. 2001 Mar;43(3):211-8 11895102 - Life Sci. 2002 Feb 15;70(13):1509-18 10066673 - Circ Res. 1999 Mar 5;84(4):392-400 13650640 - Arch Biochem Biophys. 1959 May;82(1):70-7 9577950 - Circulation. 1998 Apr 14;97(14):1382-91 6295497 - Biochim Biophys Acta. 1982 Nov 12;713(2):333-43 6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2 3456345 - J Biol Chem. 1986 Mar 5;261(7):3060-7 9718077 - Life Sci. 1998;63(7):511-21 7598835 - Boll Chim Farm. 1995 Feb;134(2):69-76 14502845 - Nutr Cancer. 1994;22(2):163-73 5085551 - Biochem J. 1972 Jun;128(1):147-59 3690411 - Can J Physiol Pharmacol. 1987 Sep;65(9):1957-65 4590654 - Ann Intern Med. 1974 Feb;80(2):249-59 8755992 - Circ Res. 1996 Aug;79(2):162-73 7805190 - Circulation. 1995 Jan 1;91(1):10-5 1377736 - J Histochem Cytochem. 1992 Aug;40(8):1203-10 7760384 - J Mol Cell Cardiol. 1995 Jan;27(1):65-74 8368352 - Am J Physiol. 1993 Aug;265(2 Pt 2):H484-93 |
References_xml | – start-page: 673 volume-title: In: Methods of Enzymatic Analysis year: 1974 ident: 50_CR4 doi: 10.1016/B978-0-12-091302-2.50032-3 – volume: 266 start-page: 1699 year: 1993 ident: 50_CR2 publication-title: J Pharmacol Exp Ther – volume: 63 start-page: 511 year: 1998 ident: 50_CR22 publication-title: Life Sci doi: 10.1016/S0024-3205(98)00302-6 – volume: 43 start-page: 211 issue: 3 year: 2001 ident: 50_CR27 publication-title: Pharmacol Res doi: 10.1006/phrs.2000.0769 – volume: 63 start-page: 511 issue: 7 year: 1998 ident: 50_CR28 publication-title: Life Sci doi: 10.1016/S0024-3205(98)00302-6 – volume: 62 start-page: 865 year: 1978 ident: 50_CR3 publication-title: Cancer Treat Rep – volume: 265 start-page: H484 year: 1993 ident: 50_CR8 publication-title: Am J Physiol – volume: 95 start-page: 351 year: 1979 ident: 50_CR17 publication-title: Annals of Biochemistry doi: 10.1016/0003-2697(79)90738-3 – volume: 134 start-page: 69 year: 1995 ident: 50_CR11 publication-title: Boll Chim Farm – volume: 42 start-page: 440 year: 1998 ident: 50_CR30 publication-title: Ind J Physiol Pharmacol – volume: 97 start-page: 1382 year: 1998 ident: 50_CR34 publication-title: Circulation doi: 10.1161/01.CIR.97.14.1382 – volume: 40 start-page: 1203 issue: 8 year: 1992 ident: 50_CR23 publication-title: J Histochem Cytochem doi: 10.1177/40.8.1377736 – volume: 77 start-page: 325 year: 1981 ident: 50_CR21 publication-title: Methods in Enzymology doi: 10.1016/S0076-6879(81)77046-0 – volume: 713 start-page: 333 issue: 2 year: 1982 ident: 50_CR25 publication-title: Biochim Biophys Acta doi: 10.1016/0005-2760(82)90251-X – volume: 82 start-page: 70 year: 1959 ident: 50_CR18 publication-title: Arch Biochem Biophy doi: 10.1016/0003-9861(59)90090-6 – volume: 22 start-page: 163 year: 1994 ident: 50_CR29 publication-title: Nutr Cancer doi: 10.1080/01635589409514341 – volume: 65 start-page: 439 year: 1998 ident: 50_CR14 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(97)01297-6 – volume: 1 start-page: 147 year: 1972 ident: 50_CR16 publication-title: Biochem J doi: 10.1042/bj1280147 – volume: 261 start-page: 3060 year: 1986 ident: 50_CR24 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)35746-0 – volume: 84 start-page: 392 year: 1999 ident: 50_CR15 publication-title: Cir Res doi: 10.1161/01.RES.84.4.392 – volume-title: New York: Oxford University Press Inc year: 1989 ident: 50_CR31 – volume: 80 start-page: 249 year: 1974 ident: 50_CR1 publication-title: Ann Intern Medicine doi: 10.7326/0003-4819-80-2-249 – volume: 28 start-page: 1063 issue: 9 year: 1994 ident: 50_CR7 publication-title: Ann Pharmacother doi: 10.1177/106002809402800912 – volume: 88 start-page: 5360 year: 1991 ident: 50_CR32 publication-title: Proc Nat Acad Sci doi: 10.1073/pnas.88.12.5360 – volume: 81 start-page: 627 year: 1997 ident: 50_CR33 publication-title: Circ Res doi: 10.1161/01.RES.81.4.627 – volume: 276 start-page: 65 year: 1995 ident: 50_CR9 publication-title: J Mol Cell cardiol doi: 10.1016/S0022-2828(08)80008-9 – start-page: 673 volume-title: In: Methods of Enzymatic Analysis year: 1974 ident: 50_CR19 doi: 10.1016/B978-0-12-091302-2.50032-3 – volume: 91 start-page: 10 issue: 1 year: 1995 ident: 50_CR10 publication-title: Circulation doi: 10.1161/01.CIR.91.1.10 – volume: 10 start-page: 53 issue: suppl-1 year: 1983 ident: 50_CR5 publication-title: Semin Oncol – volume: 70 start-page: 1509 issue: 13 year: 2002 ident: 50_CR12 publication-title: Life Sciences doi: 10.1016/S0024-3205(01)01514-4 – volume: 65 start-page: 1957 year: 1987 ident: 50_CR26 publication-title: Can J Physiol Pharmacol doi: 10.1139/y87-305 – volume: 2 start-page: 16 year: 2002 ident: 50_CR13 publication-title: BMC Pharmacol doi: 10.1186/1471-2210-2-16 – volume: 336 start-page: 1066 issue: 15 year: 1997 ident: 50_CR36 publication-title: N Engl J Med doi: 10.1056/NEJM199704103361506 – volume: 21 start-page: 130 year: 1984 ident: 50_CR20 publication-title: Ind J Biochem Biophys – volume: 79 start-page: 162 issue: 2 year: 1996 ident: 50_CR35 publication-title: Circ Res doi: 10.1161/01.RES.79.2.162 – volume: 22 start-page: 698 issue: 7 year: 1999 ident: 50_CR6 publication-title: Biol Pharm Bull doi: 10.1248/bpb.22.698 – reference: 9577950 - Circulation. 1998 Apr 14;97(14):1382-91 – reference: 3456345 - J Biol Chem. 1986 Mar 5;261(7):3060-7 – reference: 10066673 - Circ Res. 1999 Mar 5;84(4):392-400 – reference: 7760384 - J Mol Cell Cardiol. 1995 Jan;27(1):65-74 – reference: 6340204 - Semin Oncol. 1983 Mar;10(1 Suppl 1):53-5 – reference: 9718077 - Life Sci. 1998;63(7):511-21 – reference: 10443465 - Biol Pharm Bull. 1999 Jul;22(7):698-702 – reference: 7803884 - Ann Pharmacother. 1994 Sep;28(9):1063-72 – reference: 1377736 - J Histochem Cytochem. 1992 Aug;40(8):1203-10 – reference: 11895102 - Life Sci. 2002 Feb 15;70(13):1509-18 – reference: 8368352 - Am J Physiol. 1993 Aug;265(2 Pt 2):H484-93 – reference: 8755992 - Circ Res. 1996 Aug;79(2):162-73 – reference: 3690411 - Can J Physiol Pharmacol. 1987 Sep;65(9):1957-65 – reference: 9091804 - N Engl J Med. 1997 Apr 10;336(15):1066-71 – reference: 8371168 - J Pharmacol Exp Ther. 1993 Sep;266(3):1699-704 – reference: 7805190 - Circulation. 1995 Jan 1;91(1):10-5 – reference: 12182765 - BMC Pharmacol. 2002 Aug 16;2:16 – reference: 9485242 - Ann Thorac Surg. 1998 Feb;65(2):439-43 – reference: 14502845 - Nutr Cancer. 1994;22(2):163-73 – reference: 2052612 - Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5360-3 – reference: 11401411 - Pharmacol Res. 2001 Mar;43(3):211-8 – reference: 667860 - Cancer Treat Rep. 1978 Jun;62(6):865-72 – reference: 6490072 - Indian J Biochem Biophys. 1984 Apr;21(2):130-2 – reference: 36810 - Anal Biochem. 1979 Jun;95(2):351-8 – reference: 5085551 - Biochem J. 1972 Jun;128(1):147-59 – reference: 13650640 - Arch Biochem Biophys. 1959 May;82(1):70-7 – reference: 10874342 - Indian J Physiol Pharmacol. 1998 Oct;42(4):440-52 – reference: 7329310 - Methods Enzymol. 1981;77:325-33 – reference: 4590654 - Ann Intern Med. 1974 Feb;80(2):249-59 – reference: 6295497 - Biochim Biophys Acta. 1982 Nov 12;713(2):333-43 – reference: 9314845 - Circ Res. 1997 Oct;81(4):627-35 – reference: 7598835 - Boll Chim Farm. 1995 Feb;134(2):69-76 |
SSID | ssj0017847 |
Score | 1.954319 |
Snippet | Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes the heart... BACKGROUND: Oxidative stress is the major etiopathological factor in adriamycin-induced cardiotoxicity. Relatively low amounts of endogenous antioxidant makes... |
SourceID | pubmedcentral biomedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 16 |
SubjectTerms | Animals Antioxidants - physiology Body Weight Cardiomyopathies - chemically induced Cardiomyopathies - pathology Cardiomyopathies - prevention & control Catalase - metabolism Doxorubicin - adverse effects Garlic - chemistry Gene Expression - drug effects Gene Silencing - drug effects Glutathione - metabolism Myocardium - metabolism Organ Size Plant Preparations - therapeutic use Probucol - therapeutic use Rats Superoxide Dismutase - metabolism Tumor Necrosis Factor-alpha - genetics Tumor Necrosis Factor-alpha - metabolism |
Title | Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression |
URI | https://www.ncbi.nlm.nih.gov/pubmed/14687418 https://www.proquest.com/docview/71576179 http://dx.doi.org/10.1186/1471-2210-3-16 https://pubmed.ncbi.nlm.nih.gov/PMC324401 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgbNig8h4exQtUNjUkTvxIJYQQYlQhtRqhGak7y3bsNlKa0OlUmnwCn8OP8E1cJxlCOrBhGdlOFN-3fHwuQq8ZlFuMZjmJPbUk1TIlBqI0yQSzUS6SRLfdG45P-NEi_XLKTgf8U7-BV38t7UI_qcWyfLu-bD6Awb9vDV7ydzE4WEJpcCgk5rfRHYhKIhjpcTqcKAhwwz1p4_aaQB2achmYXG5cfC_H8WorCb2JpfwjOE130b0-q8QfOzW4j2656gHan3W01M0Bng-3rK4O8D6eDYTVzUP0fdaRNYCIsD7TBWSMWNvrlcM6B_28aGxREajdQQtybFsA66peFxYSeGwafKaXZWEP8de6dLj22FV53VG_Yh2wlOsiD2AbeMhxUZ0XpkWJhZnzkyn5-QO7dY_GrR6hxfTz_NMR6Vs0EJMwyQn4B5_HTtPcZ4yxxHPvjYhyyRPHhDCCWpEalmRcU-d5lnkfydQxL73Pksgkj9FOVVfuKcLgdA2jjmZcQtHpmIREKeZZGllnmNN8gg5HglHfOjoOFQiyxyNgqyoIWAUBq0TFsJhspKhsT34eenCUqi2CJN-a_-b3_M13_jXz1UYpFFhmOG7RlYMtViKGWg783QQ96VRkeFOvaxPER8oz-qXxSFWct9zfkP9CRfzsfxc-R3c7NCIF9_gC7ayW1-4lZFUrsxdiGttrjeYXsGsmzg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protection+against+acute+adriamycin-induced+cardiotoxicity+by+garlic%3A+Role+of+endogenous+antioxidants+and+inhibition+of+TNF-%CE%B1+expression&rft.jtitle=BMC+pharmacology&rft.au=Mukherjee%2C+Sumanta&rft.au=Banerjee%2C+Sanjay+Kumar&rft.au=Maulik%2C+Mohua&rft.au=Dinda%2C+Amit+Kumar&rft.date=2003-12-20&rft.pub=BioMed+Central&rft.eissn=1471-2210&rft.volume=3&rft.spage=16&rft.epage=16&rft_id=info:doi/10.1186%2F1471-2210-3-16&rft_id=info%3Apmid%2F14687418&rft.externalDocID=PMC324401 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2210&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2210&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2210&client=summon |